Terapia por protões para cancro da próstata em Amethyst Radiotherapy Austria

Amethyst Radiotherapy Austria is a radiation oncology center in Austria built around modern, high-precision treatment technology for cancer care. The clinic is known for using a state-of-the-art Elekta (Versa HD) medical linear accelerator as the core of its radiotherapy capability. With this device, Amethyst can carry out standard radiation therapy procedures and supports advanced techniques including stereotactic VMAT. In practice, patients benefit from imaging-based accuracy: planning relies on MRI, computed tomography (CT), and in some cases PET scans to define the target precisely by size, shape, and position. The clinic’s planning workflow is enhanced by techniques such as IMRT and VMAT, while Multileaf Collimators (MLC) shape radiation fields to conform to the tumour region. For image-guided delivery, Amethyst uses an integrated ConeBeam-CT visualisation system to support real-time imaging during treatment, helping clinicians target with high precision. Amethyst also highlights patient-centred planning, describing that care teams create personalised treatment plans that outline the type of radiotherapy and the number and frequency of sessions. Treatment is typically delivered in planned sessions over several weeks, with most patients receiving therapy five days per week (Monday to Friday) and a break on the weekend; some patients may be treated more than once per day or over the weekend. For international patients, Amethyst positions its Patient Services team as support throughout consultations, examinations, and treatment sessions as needed. The clinic’s focus areas include malignant diseases (including brain diseases for selected cases via Amethyst Radiotherapy UK) as well as benign conditions and chronic pain treated with low-dose radiotherapy. It also provides information about patient experience and personalised care, with clinical specialists communicating on cases from the Wiener Privatklinik context. For technology expansion, Amethyst presents NovoCure TTFields as an additional non-invasive option for selected cancer types. Overall, Amethyst combines advanced linear accelerator technology (Elekta Versa HD), modern planning methods (IMRT/VMAT with MLC), and ConeBeam-CT image guidance (IGRT) with structured patient support for those seeking radiotherapy in Austria.